Improvement of intestinal peptide absorption by a synthetic bile acid derivative, cholylsarcosine

European Journal of Pharmaceutical Sciences

Volumn 10, Issue 2, 2000, Pages 133-140

  Michael, Susanne ^a   Thöle, Marc ^a   Dillmann, Ruth ^a   Fahr, Alfred ^b   Drewe, Jürgen ^c   Fricker, Gert ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c KANTONSSPITAL BASEL   (Switzerland)

Author keywords

Absorption enhancement; Bile acid; Caco 2 cells; Cholylsarcosine; Intestinal

Indexed keywords

BILE ACID; CHENODEOXYCHOLIC ACID; CHOLYLSARCOSINE; DESMOPRESSIN; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; LACTATE DEHYDROGENASE; OCTREOTIDE; OXIDOREDUCTASE; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CYTOTOXICITY; DRUG ABSORPTION; DRUG FORMULATION; ENZYME ACTIVITY; ENZYME RELEASE; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; AREA UNDER CURVE; BILE ACIDS AND SALTS; CACO-2 CELLS; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CHOLIC ACIDS; DEXTRANS; ELECTRIC IMPEDANCE; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; HUMANS; INTESTINAL ABSORPTION; MALE; MEMBRANES, ARTIFICIAL; PEPTIDES; RATS; RATS, WISTAR; SARCOSINE; STIMULATION, CHEMICAL;

EID: 0342948632     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(99)00093-7     Document Type: Article

References (34)

1. Allan R.N., Thistle J.L., Hofmann A.F. Lithocholate metabolism during chemotherapy for gallstone dissolution. II: Absorption and sulphation. Gut. 17:1976;413-419.
2. Anderberg E.K., Nyström C., Artursson P. Epithelial transport of drugs in cell culture. VII: Effects of pharmaceutical surfactant excipients and bile acids on transepithelial permeability in monolayers of human intestinal epithelial (Caco-2) cells. J. Pharm. Sci. 81:1992;879-887.
3. Aries V., Hill M.J. Degradation of steroids by intestinal bacteria. II: Enzymes catalysing the oxidoreduction of the 3a,7a and 12a-hydroxyl groups in cholic acid and the dehydroxylation of the 7-hydroxyl group. Biochem. Biophys. Acta. 202:1970;535-543.
4. Drewe J., Fricker G., Vonderscher J., Beglinger C. Enteral absorption of octreotide: absorption enhancement by polyoxyethylene-24-cholesterol ether. Br. J. Pharmacol. 108:1993;298-303.
5. Eusufzai S. Bile acid malabsorption: mechanisms and treatment. Dig. Dis. 13:1995;312-321.
6. Franz J.M., Vonderscher J.P. Enhancement of the intestinal absorption of ergot peptide alkaloids in the rat by micellar solutions of polyoxyethylene-24-cholesteryl ether. J. Pharm. Pharmacol. 33:1981;565-568.
7. Fricker G., Bruns C., Munzer J., Albert R., Kissel K., Briner U., Vonderscher J. Intestinal absorption of SMS 201-995 visualized by fluorescence derivatization. Gastroenterology. 100:1991;1544-1552.
8. Fricker G., Drewe J., Vonderscher J., Kissel T., Beglinger C. Enteral absorption of octreotide. Br. J. Pharmacol. 105:1992;783-786.
9. Fricker G., Drewe J., Fahr A., Kissel T., Beglinger C. Permeation enhancement of octreotide by specific bile salts in rats and human subjects. In vitro-in vivo correlations. Br. J. Pharmacol. 117:1996;217-223.
10. Hidalgo I.J., Borchardt R.T. Transport of bile salts in a human intestinal epithelial cell line, Caco-2. Biochim. Biophys. Acta. 1035:1990;97-103.
11. Hill M. Epidemiology and etiology of colon cancer. Grundmann E. Colon Cancer. Cancer Campaign. Vol. 2:1978;115-127 Fischer, Stuttgart, New York.
12. Hirata T., Ukawa H., Yamakuni H., Kato S., Takeuchi K. Cyclo-oxygenase isozymes in mucosal ulcerogenic and functional responses following barrier disruption in rat stomachs. Br. J. Pharmacol. 122:1997;447-454.
13. Hoffman A.F. Defective biliary secretion during total parenteral nutrition: probable mechanisms and possible solutions. J. Pediatr. Gastroenterol. Nutr. 20:1995;376-390.
14. Hurni M.A., Noach A.B., Blom-Roosemalen M.C., de Boer A.G., Nagelkerke J.F., Breimer D.D. Permeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy. J. Pharmacol. Exp. Ther. 267:1993;942-950.
15. Ishiyama M., Tominaga H., Shiga M., Sasamoto K., Ohkura Y., Ueno K. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol. Pharm. Bull. 19:1996;1518-1520.
16. Kameyama J., Suzuki A., Tsukamoto M., Suzuki Y., Kaneko K. Effects of bile acids and bilirubin on bicarbonate secretion of isolated guinea pig antrum. J. Clin. Gastroenterol. 14:(Suppl 1):1992;S102-S106.
17. Kandell R.L., Bernstein C. Bile salt/acid induction of DNA damage in bacterial and mammalian cells: implications for colon cancer. Nutr. Cancer. 16:1991;227-238.
18. Kahns A.H., Buur A., Bundgaard H. Prodrugs of peptides. 18: Synthesis and evaluation of various esters of desmopressin (dDAVP). Pharm. Res. 10:1993;68-74.
19. Kissel T., Drewe J., Bantle S., Rummelt A., Beglinger C. Tolerability and absorption enhancement of intranasally administered octreotide by sodium taurodihydrofusidate in healthy subjects. Pharm. Res. 9:1992;52-57.
20. Kobori O., Shimizu T., Maeda M., Atomi Y., Watanabe J., Shoji M., Morioka Y. Enhancing effect of bile and bile acid on stomach tumorigenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine in Wistar rats. J. Natl. Cancer Inst. 73:1984;853-861.
21. LaRusso N.F., Hoffmann N.E., Hofmann A.F., Northfield T.C., Thistle J.L. Effect of primary bile acid ingestion on bile acid metabolism and biliary lipid secretion in gallstone patients. Gastroenterology. 69:1975;1301-1314.
22. Latta R.K., Fiander H., Ross N.W., Simpson C., Schneider H. Toxicity of bile acids to colon cancer cell lines. Cancer Lett. 70:1993;167-173.
23. Lillienau J., Schteingart C.D., Hofmann A.F. Physicochemical and physiological properties of cholylsarcosine. A potential replacement detergent for bile acid deficiency states in the small intestine. J. Clin. Invest. 89:1992;420-431.
24. Longmire-Cook S.J., Lillienau J., Kim Y.S., Schteingart C.D., Danzinger R.G., Esch O., Hofmann A.F. Effect of replacement therapy with cholylsarcosine on fat malabsorption associated with severe bile acid malabsorption. Studies in dogs with ileal resection. Dig. Dis. Sci. 37:1992;1217-1227.
25. Marcus S.N., Heaton K.W. Intestinal transit, deoxycholic acid and the cholesterol saturation of bile - three inter-related factors. Gut. 27:1986;550-558.
26. Morimoto K., Akatsuchi H., Morisaka K., Kamada A. Effect of non-ionic surfactants in a polyacrylic acid gel base on the rectal absorption of [Asu1,7]-eel calcitonin in rats. J. Pharm. Pharmacol. 37:1985;759-760.
27. Nair P., Turjman N. Role of bile acids and neutral sterols in family cancer syndromes of the colon. Dis. Colon Rectum. 26:1983;629-632.
28. Schmassmann A., Angellotti M.A., Ton-Nu H.T., Schteingart C.D., Marcus S.N., Rossi S.S., Hofmann A.F. Transport, metabolism and effect of chronic feeding of cholylsarcosine, a conjugated bile acid resistant to deconjugation and dehydroxylation. Gastroenterology. 98:1990;163-174.
29. Schmassmann A., Fehr H.F., Locher J., Lillienau J., Schteingart C.D., Rossi S.S., Hofmann A.F. Cholylsarcosine, a new bile acid analogue: metabolism and effect on biliary secretion in humans. Gastroenterology. 104:1993;1171-1181.
30. Scott Moncrieff J.C., Shao Z., Mitra A.K. Enhancement of intestinal insulin absorption by bile salt-fatty acid mixed micelles in dogs. J. Pharm. Sci. 83:1994;1465-1469.
31. Tengamnuay P., Mitra A.K. Bile salt-fatty acid mixed micelles as nasal absorption promoters of peptides. II: In vivo nasal absorption of insulin in rats and effects of mixed micelles on the morphological integrity of the nasal mucosa. Pharm. Res. 7:1990;370-375.
32. van Hoogdalem E.J., Heiljligers-Feijen C.D., Mathot R.A.A., Wackwitz A.T.E., van Bree J.B.M.M., Verhoef J.B., de Boer A.G., Breimer D.D. Rectal absorption enhancement of cefoxitin and desglycinamide arginine vasopressin by sodium tauro-24,25-dihydrofusidate in conscious rats. J. Pharmacol. Exp. Ther. 251:1989;741-744.
33. van Hoogdalem E.J., Heijligers-Feijen C.D., Verhoef J.C., De Boer A.G., Breimer D.D. Absorption enhancement of rectally infused insulin by sodium tauro-24,25-dihydrofusidate (STDHF) in rats. Pharm. Res. 7:1990;180-183.
34. Werner U., Kissel T., Reers M. Effects of permeation enhancers on the transport of a peptidomimetic thrombin inhibitor (CRC 220) in a human intestinal cell line (Caco-2). Pharm. Res. 13:1996;1219-1227.